Physician profile
Stephen Fishman
NPI 1841393931
$1,210.17
in general payments reported to CMS, 2019-2025
20 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.51 · 2020: $27.85 · 2021: $37.01 · 2022: $180 · 2023: $307 · 2024: $274 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $892.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $223.71 | 2022-2024 | |
| Exact Sciences Corporation | $186.01 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $141.31 | 2024-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $87.19 | 2021-2023 | |
| Coopersurgical, INC. | $83.77 | 2024-2025 | Paragard T 380a |
| Sage Therapeutics, LLC | $72.17 | 2025 | Zurzuvae |
| Exeltis, USA INC. | $56.84 | 2019-2025 | Slynd |
| Ge Healthcare | $51.25 | 2022 | |
| Lilly USA, LLC | $45.35 | 2025 | Zepbound |
| Agile Therapeutics, INC. | $40.75 | 2021-2023 | Twirla |
| Myovant Sciences INC. | $39.86 | 2022 | |
| Avion Pharmaceuticals | $27.85 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.22 | 2023 | |
| Nobel Biocare USA | $22.13 | 2023 | Nobelactive |
| Ormco Corporation | $22.13 | 2023 | Spark |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $19.62 | 2023 | Nexplanon |
| Millicent US INC | $18.46 | 2025 | Intrarosa, Femring |
| Sumitomo Pharma America, INC. | $18.44 | 2024 | Myfembree |
| Allergan, INC. | $15.76 | 2019 | |
| Kci USA, INC. | $14.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Fishman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.